You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动 | 康希诺生物-B(6185.HK)逆势涨4.6% 旗下鼻喷雾式/吸入型新冠疫苗正在申请紧急使用
格隆汇 06-04 09:42
格隆汇6月4日丨康希诺生物-B(6185.HK)逆势涨4.6%,报332港元;康希诺(688185.SH)亦涨逾4%。中国工程院院士陈薇在昨日举行的浦江论坛上表示,疫苗既可以通过皮下注射,还可以通过鼻喷雾式吸入,后者所需的剂量是前者的1/5,而且可以形成黏膜免疫。“鼻喷雾式/吸入型新冠疫苗正在申请紧急使用。”6月2日,康希诺董事长兼CEO宇学峰在青岛的一次会议上表示,康希诺的鼻喷雾式/吸入型新冠疫苗现已进入二期临床试验。另据港交所披露文件,5月31日,摩根大通在康希诺生物(06185.HK)的持股比例从5.92%上升至9.25%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account